Form 8-K - Current report:
SEC Accession No. 0000950137-04-003963
Filing Date
2004-05-12
Accepted
2004-05-12 15:25:54
Documents
4
Period of Report
2004-05-12
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT c85446e8vk.txt 8-K 4633
2 FORM OF SUBSCRIPTION AGREEMENT c85446exv10w1.txt EX-10.1 67973
3 FORM OF WARRANT c85446exv10w2.txt EX-10.2 27369
4 NEWS RELEASE c85446exv99w1.txt EX-99.1 5572
  Complete submission text file 0000950137-04-003963.txt   107588
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 04799239
SIC: 2836 Biological Products, (No Diagnostic Substances)